◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › A › AORT

Artivion Inc (AORT) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-17

Artivion Inc (AORT) operates in the MEDICAL DEVICES industry and is headquartered in Kennesaw, United States with about 1,800 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, AORT reported $441M in revenue and $10M in net income.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Interactive charts & full statements → Open the AORT valuation workbench →

AORT Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$471M	$441M	$389M	$354M	$314M	$299M	$253M	$276M	$263M	$190M	$180M	$146M	$145M	$141M	$132M	$120M	$117M	$112M	$105M	$95M	$81M
Gross Profit	$296M	$270M	$249M	$229M	$203M	$198M	$168M	$183M	$173M	$129M	$119M	$91M	$91M	$90M	$85M	$76M	$68M	$70M	$68M	$59M	$44M
Gross Margin %	62.8%	61.3%	64.0%	64.7%	64.5%	66.1%	66.3%	66.3%	65.8%	67.8%	65.9%	62.2%	63.1%	64.2%	64.5%	63.4%	58.6%	62.5%	64.5%	62.5%	54.0%
Operating Income (EBIT)	$19M	$27M	$39M	$6M	$6M	$8M	$2M	$17M	$9M	$8M	$22M	$5M	$9M	$14M	$13M	$12M	$10M	$14M	$14M	$8M	($1M)
Operating Margin %	4.0%	6.1%	10.0%	1.6%	2.0%	2.7%	1.0%	6.2%	3.5%	4.2%	12.1%	3.7%	6.1%	9.8%	9.6%	9.7%	8.5%	13.0%	13.0%	8.8%	-1.5%
Net Income	($3M)	$10M	($13M)	($31M)	($19M)	($15M)	($17M)	$2M	($4M)	$4M	$11M	$4M	$7M	$16M	$8M	$7M	$4M	$9M	$33M	$7M	$0M
Net Margin %	-0.7%	2.2%	-3.4%	-8.7%	-6.1%	-5.0%	-6.6%	0.6%	-1.5%	1.9%	6.0%	2.8%	5.1%	11.5%	6.0%	6.2%	3.4%	7.8%	31.3%	7.6%	0.4%
EBITDA	$57M	$64M	$51M	$27M	$26M	$26M	$20M	$35M	$30M	$18M	$25M	$11M	$15M	$20M	$18M	$17M	$11M	$19M	$18M	$13M	$4M
Earnings Per Share (EPS)	$-0.07	$0.21	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.10	$0.11	$0.33	$0.14	$0.26	$0.58	$0.29	$0.27	$0.14	$0.31	$1.16	$0.27	$0.01
Shares Outstanding (M)	49M	47M	42M	41M	40M	39M	38M	38M	36M	34M	33M	29M	28M	28M	27M	28M	28M	28M	28M	27M	25M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AORT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$126M	$116M	$116M	$113M	$113M	$99M	$97M	$96M
Gross Profit	$81M	$72M	$70M	$74M	$73M	$64M	$62M	$61M
Gross Margin %	64.0%	61.5%	60.1%	65.6%	64.7%	64.2%	63.2%	63.7%
Operating Income (EBIT)	($8M)	$7M	$7M	$13M	$8M	$2M	$3M	$4M
Operating Margin %	-6.7%	6.4%	6.2%	11.1%	7.4%	2.2%	2.7%	4.6%
Net Income	($14M)	$1M	$2M	$7M	$1M	($1M)	($16M)	($2M)
Net Margin %	-10.7%	1.2%	2.1%	5.7%	1.2%	-0.5%	-16.9%	-2.4%
EBITDA	$9M	$12M	$18M	$19M	$16M	$11M	($1M)	$13M
Earnings Per Share (EPS)	$-0.28	$0.03	$0.05	$0.13	$0.03	$-0.01	$-0.39	$-0.05
Shares Outstanding (M)	49M	50M	50M	49M	45M	42M	42M	42M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AORT Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$40M	$38M	$22M	$19M	($5M)	($3M)	$12M	$16M	$10M	$11M	$20M	$11M	$8M	$17M	$19M	$17M	$21M	$17M	$10M	$9M	($1M)
Capital Expenditures (CapEx)	$51M	$39M	$11M	$7M	$11M	$13M	$7M	$8M	$6M	$7M	$7M	$4M	$5M	$4M	$3M	$3M	$8M	$2M	$2M	$1M	$2M
Free Cash Flow (FCF)	($11M)	($1M)	$11M	$11M	($16M)	($16M)	$5M	$8M	$4M	$4M	$12M	$7M	$3M	$12M	$16M	$14M	$13M	$15M	$8M	$8M	($3M)
FCF Margin %	-2.3%	-0.2%	2.8%	3.2%	-5.1%	-5.2%	2.0%	2.8%	1.6%	2.0%	6.8%	5.0%	1.9%	8.8%	12.1%	11.9%	11.4%	13.3%	7.4%	8.5%	-3.3%
Dividends Paid	—	—	—	—	—	$4M	$2M	$5M	—	—	—	$3M	$3M	$3M	$1M	—	—	—	—	$0M	$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AORT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	($1M)	$1M	$20M	$21M	$15M	($17M)	$10M	$11M
Capital Expenditures (CapEx)	$11M	$8M	$28M	$5M	$3M	$4M	$1M	$4M
Free Cash Flow (FCF)	($12M)	($7M)	($8M)	$16M	$12M	($21M)	$9M	$8M
FCF Margin %	-9.6%	-5.9%	-6.9%	14.0%	10.4%	-20.8%	9.0%	8.2%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AORT Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$1.1B	$885M	$789M	$792M	$763M	$793M	$789M	$606M	$571M	$592M	$316M	$181M	$176M	$175M	$157M	$148M	$137M	$134M	$126M	$93M	$80M
Cash & Cash Equivalents	$77M	$65M	$53M	$59M	$39M	$55M	$61M	$34M	$41M	$41M	$57M	$43M	$33M	$43M	$18M	$22M	$35M	$30M	$17M	$14M	$4M
Total Liabilities	$626M	$437M	$513M	$511M	$478M	$492M	$461M	$320M	$296M	$313M	$107M	$26M	$27M	$30M	$29M	$26M	$23M	$23M	$27M	$30M	$28M
Total Debt (Short + Long-Term)	$369M	$220M	$319M	$311M	$312M	$313M	$298M	$222M	$218M	$2M	$5M	$0M	$0M	$14M	$14M	$13M	$11M	$11M	$14M	$5M	$5M
Total Shareholders' Equity	$446M	$448M	$276M	$282M	$284M	$301M	$329M	$286M	$275M	$279M	$209M	$155M	$149M	$145M	$128M	$122M	$114M	$110M	$99M	$63M	$52M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AORT viewer.

Other Companies in MEDICAL DEVICES

ATEC · Alphatec Holdings Inc — $2 billion
CNMD · CONMED Corporation — $1 billion
IART · Integra LifeSciences Holdings — $1 billion
TNDM · Tandem Diabetes Care Inc — $1 billion
PRCT · Procept Biorobotics Corp — $1 billion
LMRI · Lumexa Imaging Holdings, Inc. Common Stock — $1 billion
IRMD · Iradimed Co — $1 billion
ENOV · Enovis Corp — $1 billion

← AOR All “A” companies AOS →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.